Overview
PRKAR1B-related neurodegenerative dementia with intermediate filaments is a rare brain disease caused by changes (mutations) in the PRKAR1B gene. This condition leads to a slow but progressive loss of brain function, meaning it gets worse over time. The disease is sometimes referred to by its gene name, PRKAR1B-related neurodegeneration, and it belongs to a broader group of conditions called neurodegenerative diseases — illnesses where nerve cells in the brain gradually stop working and die. The PRKAR1B gene normally helps control how cells respond to chemical signals inside the body. When this gene is not working correctly, abnormal protein clumps called intermediate filaments build up inside brain cells. These clumps damage and eventually destroy nerve cells, leading to problems with memory, thinking, movement, and behavior. The damage tends to affect multiple areas of the brain over time. The main symptoms include progressive memory loss, personality and behavior changes, difficulty with movement and coordination, and eventually significant cognitive decline (dementia). Currently, there is no cure for this condition, and treatment focuses on managing symptoms and supporting quality of life. Because this disease is extremely rare and was only recently described, research is still in early stages, and specialists are still learning about its full range of effects and best management strategies.
Key symptoms:
Progressive memory loss and forgetfulnessPersonality and behavior changesDifficulty thinking clearly or making decisionsProblems with movement and coordinationMuscle stiffness or rigiditySlowed movements (parkinsonism-like features)Difficulty speaking or finding wordsMood changes including depression or anxietyLoss of independence in daily activitiesGradual decline in overall brain function (dementia)
Clinical phenotype terms (23)— hover any for plain English
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for PRKAR1B-related neurodegenerative dementia with intermediate filaments.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for PRKAR1B-related neurodegenerative dementia with intermediate filaments at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for PRKAR1B-related neurodegenerative dementia with intermediate filaments.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to PRKAR1B-related neurodegenerative dementia with intermediate filaments.
Community
No community posts yet. Be the first to share your experience with PRKAR1B-related neurodegenerative dementia with intermediate filaments.
Start the conversation →Latest news about PRKAR1B-related neurodegenerative dementia with intermediate filaments
No recent news articles for PRKAR1B-related neurodegenerative dementia with intermediate filaments.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What stage is the disease at right now, and what changes should I expect in the coming months or years?,Should other family members be tested for the PRKAR1B gene mutation?,Are there any clinical trials or research studies I or my family member could participate in?,What symptoms should prompt me to call you or go to the emergency room?,What therapies — physical, occupational, or speech — would be most helpful right now?,How do I plan ahead for future care needs, including legal and financial decisions?,Are there any specialist centers or expert teams that focus on this specific condition?
Common questions about PRKAR1B-related neurodegenerative dementia with intermediate filaments
What is PRKAR1B-related neurodegenerative dementia with intermediate filaments?
PRKAR1B-related neurodegenerative dementia with intermediate filaments is a rare brain disease caused by changes (mutations) in the PRKAR1B gene. This condition leads to a slow but progressive loss of brain function, meaning it gets worse over time. The disease is sometimes referred to by its gene name, PRKAR1B-related neurodegeneration, and it belongs to a broader group of conditions called neurodegenerative diseases — illnesses where nerve cells in the brain gradually stop working and die. The PRKAR1B gene normally helps control how cells respond to chemical signals inside the body. When th
How is PRKAR1B-related neurodegenerative dementia with intermediate filaments inherited?
PRKAR1B-related neurodegenerative dementia with intermediate filaments follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does PRKAR1B-related neurodegenerative dementia with intermediate filaments typically begin?
Typical onset of PRKAR1B-related neurodegenerative dementia with intermediate filaments is adult. Age of onset can vary across affected individuals.